GMAB:VIE
Genmab A/S
€290.10
arrow_downward
-1.36%(-4.00) 1D
Sep 4, 5:36:00 PM GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GMAB...
Open
€294.70
High
€294.70
Low
€290.10
Mkt. cap
20.73B
Avg. vol.
23.00
Volume
0.00
52-wk high
€302.40
52-wk low
€203.90
No. of employees
3K
Open
€294.70
High
€294.70
Low
€290.10
Mkt. cap
20.73B
Avg. vol.
23.00
Volume
0.00
52-wk high
€302.40
52-wk low
€203.90
No. of employees
3K
Profile
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, Genmab K.K. in Tokyo, Japan, Genmab Germany GmbH in München, Germany and Genmab Co., Ltd. in Suzhou, China. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US. Wikipedia
About Genmab A/S
CEOJan G. J. van de Winkel
Employees3.12K
Founded1999
Headquarters-
SectorBiotechnology
Websitegenmab.com